Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Subarachnoid Hemorrhage | 2 | 2020 | 91 | 0.770 |
Why?
|
| Hydrocephalus | 1 | 2020 | 43 | 0.690 |
Why?
|
| Nitric Oxide | 1 | 2018 | 144 | 0.560 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 95 | 0.540 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2016 | 7 | 0.530 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2016 | 124 | 0.480 |
Why?
|
| Mitochondria | 1 | 2018 | 334 | 0.470 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2022 | 77 | 0.440 |
Why?
|
| Stroke | 4 | 2016 | 1135 | 0.430 |
Why?
|
| Brain Injuries | 4 | 2015 | 140 | 0.410 |
Why?
|
| Dura Mater | 1 | 2008 | 35 | 0.290 |
Why?
|
| Middle Cerebral Artery | 1 | 2008 | 46 | 0.290 |
Why?
|
| Cerebral Infarction | 1 | 2008 | 75 | 0.290 |
Why?
|
| Decompression, Surgical | 1 | 2008 | 61 | 0.280 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2007 | 39 | 0.270 |
Why?
|
| Thrombolytic Therapy | 2 | 2019 | 180 | 0.270 |
Why?
|
| Glasgow Coma Scale | 4 | 2022 | 44 | 0.240 |
Why?
|
| Intensive Care Units | 2 | 2022 | 446 | 0.240 |
Why?
|
| Brain Ischemia | 2 | 2019 | 403 | 0.220 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2021 | 3 | 0.190 |
Why?
|
| Infarction, Posterior Cerebral Artery | 1 | 2021 | 7 | 0.190 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2020 | 30 | 0.180 |
Why?
|
| Trauma Severity Indices | 2 | 2018 | 38 | 0.180 |
Why?
|
| Humans | 18 | 2022 | 59345 | 0.170 |
Why?
|
| Bed Rest | 1 | 2019 | 9 | 0.170 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 119 | 0.170 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2019 | 8 | 0.170 |
Why?
|
| Dexamethasone | 1 | 2020 | 191 | 0.160 |
Why?
|
| Glasgow Outcome Scale | 2 | 2016 | 17 | 0.150 |
Why?
|
| Middle Aged | 12 | 2021 | 16251 | 0.150 |
Why?
|
| Diffuse Axonal Injury | 1 | 2018 | 4 | 0.150 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2018 | 8 | 0.150 |
Why?
|
| Encephalocele | 2 | 2015 | 12 | 0.150 |
Why?
|
| Biopsy | 1 | 2019 | 373 | 0.150 |
Why?
|
| Brain Edema | 2 | 2015 | 31 | 0.150 |
Why?
|
| Cerebral Angiography | 1 | 2019 | 278 | 0.150 |
Why?
|
| Cohort Studies | 5 | 2022 | 2437 | 0.140 |
Why?
|
| Retrospective Studies | 5 | 2020 | 5981 | 0.140 |
Why?
|
| Models, Neurological | 1 | 2016 | 81 | 0.130 |
Why?
|
| Brain | 2 | 2019 | 1489 | 0.130 |
Why?
|
| Blood Gas Analysis | 1 | 2015 | 34 | 0.130 |
Why?
|
| Brain Death | 1 | 2015 | 18 | 0.130 |
Why?
|
| Apnea | 1 | 2015 | 31 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 165 | 0.120 |
Why?
|
| Thrombophilia | 1 | 2015 | 15 | 0.120 |
Why?
|
| Embolism, Paradoxical | 1 | 2015 | 14 | 0.120 |
Why?
|
| Renal Replacement Therapy | 1 | 2015 | 23 | 0.120 |
Why?
|
| Foramen Ovale, Patent | 1 | 2015 | 13 | 0.120 |
Why?
|
| Hemofiltration | 1 | 2015 | 17 | 0.120 |
Why?
|
| Dantrolene | 1 | 2014 | 7 | 0.120 |
Why?
|
| Muscle Relaxants, Central | 1 | 2014 | 12 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 164 | 0.120 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 187 | 0.120 |
Why?
|
| Vasospasm, Intracranial | 1 | 2014 | 25 | 0.120 |
Why?
|
| Leukoaraiosis | 1 | 2014 | 45 | 0.110 |
Why?
|
| Aged | 9 | 2019 | 13305 | 0.110 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 105 | 0.110 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 695 | 0.110 |
Why?
|
| Adult | 9 | 2022 | 15744 | 0.110 |
Why?
|
| White Matter | 1 | 2014 | 113 | 0.110 |
Why?
|
| Male | 12 | 2021 | 27520 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 128 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 1456 | 0.110 |
Why?
|
| Female | 11 | 2019 | 30840 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2019 | 5142 | 0.100 |
Why?
|
| Prognosis | 3 | 2022 | 1564 | 0.090 |
Why?
|
| Speech Disorders | 1 | 2008 | 16 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2008 | 133 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 1448 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2021 | 3095 | 0.070 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2007 | 71 | 0.070 |
Why?
|
| Risk | 1 | 2006 | 371 | 0.060 |
Why?
|
| Fatal Outcome | 2 | 2015 | 112 | 0.060 |
Why?
|
| Oxygen | 1 | 2007 | 307 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 1025 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2022 | 842 | 0.060 |
Why?
|
| Incidence | 1 | 2006 | 1232 | 0.050 |
Why?
|
| Disease Progression | 1 | 2007 | 1040 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 5069 | 0.050 |
Why?
|
| Animals | 1 | 2018 | 19615 | 0.040 |
Why?
|
| Leukocytosis | 1 | 2019 | 12 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 180 | 0.040 |
Why?
|
| Echocardiography | 1 | 2021 | 455 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 4321 | 0.030 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2015 | 27 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 787 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2015 | 75 | 0.030 |
Why?
|
| Respiration | 1 | 2015 | 87 | 0.030 |
Why?
|
| Hypoxia | 1 | 2015 | 107 | 0.030 |
Why?
|
| United States | 1 | 2006 | 7495 | 0.030 |
Why?
|
| Brain Hemorrhage, Traumatic | 1 | 2013 | 4 | 0.030 |
Why?
|
| Fever | 1 | 2013 | 63 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2013 | 42 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2013 | 103 | 0.030 |
Why?
|
| Hypotension | 1 | 2013 | 47 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1226 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 684 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2013 | 76 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2013 | 103 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 3567 | 0.020 |
Why?
|
| Massachusetts | 1 | 2018 | 2086 | 0.020 |
Why?
|
| Cross Infection | 1 | 2013 | 150 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 576 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 1279 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 926 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1518 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2034 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1252 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 4999 | 0.020 |
Why?
|
| Adolescent | 1 | 2015 | 5918 | 0.010 |
Why?
|